Takeda Pharmaceutical Co Ltd
TSE:4502
Relative Value
The Relative Value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 6 063.36 JPY. Compared to the current market price of 4 089 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
JP |
Takeda Pharmaceutical Co Ltd
TSE:4502
|
6.4T JPY | 1.5 | 36 | 8.9 | 22.4 | ||
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
US |
Eli Lilly and Co
NYSE:LLY
|
708.2B USD | 20.8 | 135.1 | 61 | 70.1 | ||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
3.8T DKK | 16.6 | 46 | 33.6 | 36.6 | ||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | ||
US |
Johnson & Johnson
NYSE:JNJ
|
350.8B USD | 4.1 | 10 | 11.2 | 14.7 | ||
US |
Merck & Co Inc
NYSE:MRK
|
317B USD | 5.3 | 868.6 | 43.3 | 84.5 | ||
UK |
AstraZeneca PLC
LSE:AZN
|
169.2B GBP | 4.6 | 35.3 | 139 | 223 | ||
CH |
Roche Holding AG
SIX:ROG
|
175.4B CHF | 3 | 15.3 | 8.4 | 10 | ||
CH |
Novartis AG
SIX:NOVN
|
172.8B CHF | 4.1 | 12.8 | 9.3 | 15.4 | ||
US |
Pfizer Inc
NYSE:PFE
|
143.4B USD | 2.5 | 67.7 | 10.4 | 15.5 |